Santoro A, Pilar G, Tan DSW, Zugazagoitia J, et al. Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC. BMC Cancer 2024;24:1307.
PMID: 39448966